Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verano is a leading vertically integrated multi-state cannabis operator (MSO) in the United States, dedicated to the cultivation, manufacturing, and retail of medical and adult-use cannabis products. The company produces a wide array of high-quality products under several proprietary brands, including its flagship Verano line, MÜV, Savvy, and Avexia. Its operations span across multiple states, supported by numerous cultivation and processing facilities and a vast network of retail dispensaries under the Zen Leaf and MÜV banners. Verano's product portfolio includes flower, pre-rolls, concentrates, edibles, and topicals designed to meet diverse patient and consumer needs. The company emphasizes premium genetics and advanced extraction techniques to ensure product consistency and efficacy. As a publicly traded entity, Verano is a significant player in the evolving legal cannabis landscape, prioritizing operational excellence and market expansion.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verano.